217 related articles for article (PubMed ID: 8640876)
1. Deletion of peripheral V beta 14+ T cells by Mtv-2-encoded viral superantigen preceded by blastogenesis and DNA synthesis but not by specific expansion.
Nakano H; Yoshimoto T; Nariuchi H; Kakiuchi T; Matsuzawa A
Cell Immunol; 1996 Mar; 168(2):281-90. PubMed ID: 8640876
[TBL] [Abstract][Full Text] [Related]
2. Transfer of endogenous retroviral superantigen from donor to recipient B cells following priming to induce peripheral T cell tolerance.
Modlin CS; Todd GT; Cohen TD; Fairchild RL
Cell Immunol; 1995 Sep; 164(2):217-26. PubMed ID: 7656330
[TBL] [Abstract][Full Text] [Related]
3. T cell deletion induced by chronic infection with mouse mammary tumor virus spares a CD25-positive, IL-10-producing T cell population with infectious capacity.
Papiernik M; do Carmo Leite-de-MoraesM ; Pontoux C; Joret AM; Rocha B; Penit C; Dy M
J Immunol; 1997 May; 158(10):4642-53. PubMed ID: 9144476
[TBL] [Abstract][Full Text] [Related]
4. Recipient polyclonal B cell activation and immunoglobulin production induced by priming with a retroviral superantigen.
Modlin CS; Muruve NA; Stanko D; Caulfield MJ; Fairchild RL
Cell Immunol; 1996 May; 169(2):252-63. PubMed ID: 8620553
[TBL] [Abstract][Full Text] [Related]
5. Quantitation of endogenous mouse mammary tumor virus superantigen expression by lymphocyte subsets.
Waanders GA; Lees RK; Held W; MacDonald HR
Eur J Immunol; 1995 Sep; 25(9):2632-7. PubMed ID: 7589137
[TBL] [Abstract][Full Text] [Related]
6. Nonspecific augmentation of lymph node T cells and I-E-independent selective deletion of V beta 14+ T cells by Mtv-2 in the DDD mouse.
Nakano H; Yoshimoto T; Kakiuchi T; Matsuzawa A
Eur J Immunol; 1993 Oct; 23(10):2434-9. PubMed ID: 8405042
[TBL] [Abstract][Full Text] [Related]
7. A V beta 4-specific superantigen encoded by a new exogenous mouse mammary tumor virus.
Maillard I; Erny K; Acha-Orbea H; Diggelmann H
Eur J Immunol; 1996 May; 26(5):1000-6. PubMed ID: 8647159
[TBL] [Abstract][Full Text] [Related]
8. Maternal transfer of infectious mouse mammary tumor retroviruses does not depend on clonal deletion of superantigen-reactive V beta 14+ T cells.
Penninger JM; Wallace VA; Timms E; Mak TW
Eur J Immunol; 1994 May; 24(5):1102-8. PubMed ID: 8181521
[TBL] [Abstract][Full Text] [Related]
9. The induction of peripheral tolerance by the chronic activation and deletion of CD4+V beta 5+ cells.
Fink PJ; Fang CA; Turk GL
J Immunol; 1994 May; 152(9):4270-81. PubMed ID: 7908916
[TBL] [Abstract][Full Text] [Related]
10. Concomitant infection with exogenous mouse mammary tumor virus encoding I-E-dependent superantigen in I-E-negative mouse strain.
Ando Y; Wajjwalku W; Niimi N; Hiromatsu K; Morishima T; Yoshikai Y
J Immunol; 1995 Jun; 154(12):6219-26. PubMed ID: 7759859
[TBL] [Abstract][Full Text] [Related]
11. Implantation of IL-2-containing osmotic pump prolongs the survival of superantigen-reactive T cells expanded in mice injected with bacterial superantigen.
Kuroda K; Yagi J; Imanishi K; Yan XJ; Li XY; Fujimaki W; Kato H; Miyoshi-Akiyama T; Kumazawa Y; Abe H; Uchiyama T
J Immunol; 1996 Aug; 157(4):1422-31. PubMed ID: 8759722
[TBL] [Abstract][Full Text] [Related]
12. Impaired peripheral deletion of activated T cells in mice lacking the common cytokine receptor gamma-chain: defective Fas ligand expression in gamma-chain-deficient mice.
Nakajima H; Leonard WJ
J Immunol; 1997 Nov; 159(10):4737-44. PubMed ID: 9366397
[TBL] [Abstract][Full Text] [Related]
13. Exogenous and endogenous antigens are differentially presented by mast cells to CD4+ T lymphocytes.
Frandji P; Tkaczyk C; Oskeritzian C; David B; Desaymard C; Mécheri S
Eur J Immunol; 1996 Oct; 26(10):2517-28. PubMed ID: 8898968
[TBL] [Abstract][Full Text] [Related]
14. Association of a V beta 2-specific superantigen with a tumorigenic milk-borne mouse mammary tumor virus.
Hodes RJ; Novick MB; Palmer LD; Knepper JE
J Immunol; 1993 Feb; 150(4):1422-8. PubMed ID: 8094408
[TBL] [Abstract][Full Text] [Related]
15. T cell receptor V beta repertoire in mice lacking endogenous mouse mammary tumor provirus.
Braun MY; Jouvin-Marche E; Marche PN; MacDonald HR; Acha-Orbea H
Eur J Immunol; 1995 Mar; 25(3):857-62. PubMed ID: 7705418
[TBL] [Abstract][Full Text] [Related]
16. The J alpha segment contributes to the affinity of V beta 6+ cells for vSAG-7 (Mls-1a) presented by I-A molecules.
Churaqui E; Oukka M; Tilloy F; Mayadoux E; Bruley-Rosset M; Kosmatopoulos K
Immunology; 1995 Apr; 84(4):609-18. PubMed ID: 7790035
[TBL] [Abstract][Full Text] [Related]
17. CD28/CTLA4-B7 interaction is dispensable for T cell stimulation by mouse mammary tumor virus superantigen but not for B cell differentiation and virus dissemination.
Champagne E; Scarpellino L; Lane P; Acha-Orbea H
Eur J Immunol; 1996 Jul; 26(7):1595-602. PubMed ID: 8766566
[TBL] [Abstract][Full Text] [Related]
18. Expression of Mtv-7 sag gene in vivo using a retroviral vector results in selective inactivation of superantigen reactive T cells.
Kang J; Ido E; Pawling J; Beutner U; Huber BT; Hozumi N
J Immunol; 1994 Feb; 152(3):1039-46. PubMed ID: 8301116
[TBL] [Abstract][Full Text] [Related]
19. Control of endogenous mouse mammary tumor virus superantigen expression in SJL lymphomas by a promoter within the env region.
Zhang DJ; Tsiagbe VK; Huang C; Thorbecke GJ
J Immunol; 1996 Oct; 157(8):3510-7. PubMed ID: 8871650
[TBL] [Abstract][Full Text] [Related]
20. Adoptive transfer of V beta 2-deleting activity with host cells from mice implanted with C4 preneoplastic hyperplastic alveolar nodules.
Wei WZ; Wang H; Ficsor-Jacobs R; Pauley R
Cancer Res; 1992 Oct; 52(19):5183-9. PubMed ID: 1327503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
